Well Referenced

Tag: PASC

A pilot randomized controlled trial of major ozone autohemotherapy for patients with post-acute sequelae of COVID-19

This randomized controlled trial investigated the effects of major ozone autohemotherapy (O₃-MAH) on patients with post-acute sequelae of COVID-19 (PASC). Seventy-three patients were assigned to receive either O₃-MAH plus conventional therapy or conventional therapy alone. The O₃-MAH group showed significantly greater improvements in symptoms, pulmonary function, and inflammatory markers, particularly

Read More »
June 26, 2025 No Comments

Fatigue in post-acute sequelae of SARS-CoV2 (PASC) treated with oxygen-ozone autohemotherapy – preliminary results on 100 patients

This study explored the efficacy of oxygen-ozone autohemotherapy (O2-O3-AHT) for treating fatigue in patients suffering from post-acute sequelae of SARS-CoV2 (PASC), also known as long COVID. The trial involved 100 patients and found that O2-O3-AHT resulted in a 67% reduction in fatigue, with 40% of patients experiencing complete recovery. The

Read More »
June 26, 2025 No Comments